915 abstracts found.
Results filter
- Year: 2008 Remove Filter
CRAd improve gene replication efficiency and cancer killing effect of E1-deleted adenovirus including killing gene in head and neck cancer cell line
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Cancer Research Institute, Seoul, Republic Of Korea
Dietary flavonoids inhibit the anti-cancer effects of the proteasome inhibitor Bortezomib
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Institute of Cell and Molecular Science, Queen Mary University of London, London, UK, 2Department of Materials /IRC in Biomedical Materials, Queen Mary University of London, London, UK, 3School of Biological and Chemical Sciences, Queen Mary University of London, London, UK, 4Centre for Experimental Cancer Medicine, Institute of Cancer, Queen Mary University of London, London, UK
Inhibiting BCL-6
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Leeds Institute of Molecular Medicine, Leeds, West Yorkshire, UK
CRT0066101, a small molecule inhibitor of protein kinase D, demonstrates in vitro and in vivo anticancer efficacy
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Cancer Research Technology Discovery Laboratories, University College London, London, UK
Identification and characterisation of small molecule inhibitors of the atypical protein kinase C family (aPKC)
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Cancer Research Technology Discovery Laboratories, University College London, London, UK, 2London Research Institute, London, UK
The αvβ6 integrin – a novel target for antibody conjugated magnetic fluid hyperthermia in squamous cell carcinoma
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Cancer Institute, UCL, London, UK, 2London Centre of Nanotechnology, London, UK, 3Royal Free Hospital, London, UK
An in vitro study of the pro‑apoptotic properties of green tea polyphenols in neoplastic cell lines
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Northumbria University, Newcastle-upon-Tyne, UK, 2Manchester Metropolitan University, Manchester, UK, 3Newcastle University, Newcastle-upon-Tyne, UK
Second-line treatment of ovarian carcinoma with pegylated liposomal doxorubicin (Caelyx®)
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Northern Ireland Cancer Centre, Belfast, Northern Ireland, UK
Changes in Ca-125 relative to response following treatment with Pegylated Liposomal Doxorubicin (Caelyx®) in ovarian carcinoma
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Northern Ireland Cancer Centre, Belfast, Northern Ireland, UK
The social impact of cancer on people of south Asian origin: staff and patient interview studies
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Bradford Institute for Health Research, Bradford Royal Infirmary, Bradford Teaching Hospitals Foundation Trust, UK
Glioma stem cell lines configured for patient-specific chemical genetic screens
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Wellcome Trust Centre for Stem Cell Research, University of Cambridge, UK, 2The Hospital for Sick Children, University of Toronto, Canada
Regulation of tumor stroma angiogenesis by fibroblast cell-derived tetrahydrobiopterin
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1University of Oxford, UK, 2College of Biology & Food Engineering, Dalian Polytechnic University, China
Molecular basis for maize as a risk factor for oesophageal cancer in a South African population via a prostaglandin E2 positive feedback mechanism
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Cranfield Health, Cranfield University, Bedfordshire, UK, 2Dept of Physiology, Faculty of Health Sciences, Walter Sisulu University, Mthatha, South Africa, 3Dept of Surgery, Gloucestershire Royal Hospital, Gloucester, UK
The tumour suppressor protein LIMD1 specifically binds the HIF-prolyl hydroxylases and pVHL and represses HIF-1 mediated transcription
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1University of Nottingham, UK, 2Washington University, St. Louis, USA
SAGE and MPSS profiling of stroma to identify regulators of prostate development and tumourigenesis
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Medical Research Council, Edinburgh, Lothian, UK, 2Vanderbilt University, Nashville, USA
Wnt-11 promotes neuroendocrine-like differentiation, cell survival and migration in advanced prostate cancer
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Imperial College London, London, UK, 2Centre for Cooperative Research in Biosciences, Bilbao, Spain
Identification of androgen receptor transcriptional complexes on distinct promoter targets
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Cancer Research UK Cambridge Research Institute, University of Cambridge, UK, 2Max-Planck-Institute, Martinsried, Germany, 3Cambridge Systems Biology Centre, University of Cambridge, UK
Setting up a multi-centre cancer biobank: key learning points
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Manchester Cancer Research Centre, Manchester, UK
Bioavailability of four different sublingual formulations of fentanyl in healthy male volunteers: Phase I, randomised, open-label, crossover study
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Orexo AB, 754 50 Uppsala, Sweden, 2ProStrakan Group plc, Galashiels, TD1 1QH, UK
Vandetanib shows potent efficacy against an EGFR dependent model of human lung cancer
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Cancer and Infection Research Area, Astrazeneca, Macclesfield, Cheshire, UK
A novel small molecule inhibits cancer cell proliferation in vitro and in vivo via activation of the protein kinase AMPK
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Antisoma Research Ltd, Welwyn Garden City, Herts, UK, 2Betagenon AB, Umeå, Sweden
Isoindolinone inhibitors of the MDM2-p53 protein-protein interaction: structure-activity studies
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Northern Institute for Cancer Research, Newcastle upon Tyne, UK
Non-invasive imaging of Mitogenic Extracellular Kinase inhibition by PD0325901
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Imperial College London, London, UK, 2Wolfson Brain Imaging Center, Cambridge, UK, 3Huddinge University Hospital, Stockholm, Sweden, 4Institute of Cancer Research Institute, Sutton, Surrey, UK
Molecular mechanisms of T cell recruitment into renal cell carcinoma
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Institute for Cancer Studies, University of Birmingham, Birmingham, UK, 2Institute of Biomedical Research, University of Birmingham, Birmingham, UK, 3Department of Urology, Queen Elizabeth Hospital, Birmingham, UK, 4Department of Pathology, Queen Elizabeth Hospital, Birmingham, UK
Development of a novel, anti-angiogenic peptide derived from the C-terminal of MMP-inhibitor, TIMP-3
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
University of Sheffield, Sheffield/South Yorkshire, UK
Use of nanomagnets to enhance monocyte delivery of gene therapy to tumours
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1University of Sheffield, Sheffield, UK, 2University of Kent, Kent, UK, 3Keele University School of Medicine, Stoke on Trent, UK
Adenovirus 11: a potential oncolytic virus for pancreatic cancer therapy?
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Centre for Molecular Oncology and Imaging, Institute of Cancer, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, London, UK
Efficient lentiviral transduction of primary mouse T cells
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1University of Manchester, Manchester, UK, 2Paterson Institute for Cancer Research, Manchester, UK
Increasing melanoma cell death using an inhibitor of protein disulphide isomerases to abrogate stress-survival responses
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Newcastle University, Newcastle upon Tyne, UK, 2L’Spallanzani National Institute for Infectious Disease, Rome, Italy
IgE antibody immunotherapy of solid tumours: A novel model targeting folate receptor with MOv18 IgE
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Division of Cancer studies, King's College London at Guy's Hospital, London, UK, 2Randall Institute, Division of Cell and Molecular Biophysics, King's College London at Guy's Hospital, London, UK, 3Division of Genetics and Molecular Medicine, King's College London at Guy's Hospital, London, UK
Patterns of bone metastases and bisphosphonate use in renal cancer patients in Leeds, UK
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1St James' Institute of Oncology, Leeds, UK, 2Cancer Research UK Academic Unit of Oncology, Leeds, UK
Immunotherapy of primary leukaemia by WT1-TCR engineered patient’s autologous T cells
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
University College London, Royal Free Hospital, London, UK
In vitro activity of the multitargeted receptor tyrosine kinase inhibitor sunitinib against multiple myeloma cell lines is not predictive of in vivo xenograft response
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Northern Institute for Cancer Research, Newcastle University, Newcastle, UK
Stimulation of VEGF-mediated angiogenesis and tumor growth by low concentrations of anti-angiogenic integrin inhibitors
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1The Adhesion and Angiogenesis Lab, 2 Centre for Tumour Biology, Cancer Research UK Clinical Centre, Institute of Cancer, Barts and The London School Of Medicine and Dentistry, John Vane Science Centre,, London, UK, 2Integrin Cell Biology Laboratory, Beatson Institute for Cancer Research, Garscube Estate, Switchback Road,, Glasgow, UK, 3Cancer Research UK London Research Institute, Clare Hall Laboratories,, London, UK, 4Technologie Servier, 5 rue Bel Air, 45000 ,, Orléans, France, 5Institut de Recherches Servier (IdRS), Medicinal Chemistry Division, 125 Chemin de Ronde, 78290, Croissy-sur-Seine, France, 6Institut de Recherches Servier (IdRS), Cancer Drug Discovery Division, 125 Chemin de Ronde, 78290, Croissy-sur-Seine, France, 7Tumour Angiogenesis Group, Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
IMPORT LOW: Changing service delivery to optimise trial recruitment
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Institute of Cancer Research, Sutton, UK, 2Cambrodge University Hospitals NHS Foundation Trust, Cambridge, UK, 3Mount Vernon Hospital, Middlesex, UK, 4NHS, National, UK
Moving UK breast radiotherapy forward in the IMPORT LOW trial – enabling safe change of practice through quality assurance (QA)
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
1Mount Vernon Hospital, Northwood, Middlesex, UK, 2National Health Service (NHS), National, UK
Using hyperpolarised helium-3 MRI to detect changes in ventilation after lung radiotherapy
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Weston Park Hospital, Sheffield, UK
Apparent diffusion coefficient histogram parameters distinguish paediatric brain tumours
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
UCL Institute of Child Health, London, UK
Does acute gastrointestinal toxicity during radical pelvic radiotherapy predict late gastrointestinal toxicity? A study using the IBDQ and a Vaizey score, more sensitive measures of radiotherapy-induced toxicity than the RTOG or LENT SOM scales
Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Royal Marsden Hospital, London, UK